Company news
MediPharm Labs Corp. news in 2026
MediPharm Labs Corp.'s news releases, calls and decks from 2026, newest first.
MediPharm Labs Appoints Greg Hunter as Chief Executive Officer and Director
November 4, 2026
MediPharm Labs Expands Its International Medical Cannabis Footprint with First CBD Metered-Dose Inhaler Shipment to Panama
October 13, 2026
MediPharm Labs Reports Positive Q2 2026 Net Income and Second Consecutive Quarter of Positive Adjusted EBITDA
August 13, 2026
MediPharm Labs Sets Date to Report Second Quarter 2026 Financial Results
August 10, 2026
MediPharm Labs Announces Positive Phase II LiBBY Trial Results Demonstrating Significant Reduction in Agitation Associated With Advanced Alzheimer’s Disease and Dementia
July 14, 2026
MediPharm Labs Announces Voting Results from the 2026 Annual and Special Meeting of Shareholders
June 17, 2026
MediPharm Labs Reminds Shareholders of Upcoming Annual and Special Meeting
May 28, 2026
MediPharm Labs Reports First Quarter 2026 Results Achieving Positive Adjusted EBITDA
May 13, 2026
MediPharm Labs Sets Date to Report First Quarter 2026 Financial Results
May 7, 2026
MediPharm Labs Positioned to Serve Growing U.S. Pharmaceutical and Clinical Research Demand Following Cannabis Rescheduling
April 27, 2026
MediPharm Labs Reports Full Year & Fourth Quarter 2025 Results with Over 40% Annual Growth in International Medical Revenue
March 30, 2026
MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2025 Financial Results
March 25, 2026
MediPharm Labs Announces CEO Transition: David Pidduck to Step Down; CFO Greg Hunter Appointed Interim CEO
January 19, 2026
MediPharm Labs to Enter New Market with Costa Rica Supply Agreement
January 13, 2026
Calls in 2026
Decks in 2026
- Q1 2026 Earnings Presentation
Earnings · 6 slides · May 13, 2026